RealFeedApp beta

CardiAMP treats ischemic heart failure

BioCardia tests CardiAMP, an autologous mononuclear cell therapy delivered via minimally invasive catheter. The platform uses the Helix system for precise tissue delivery to treat ischemic heart failure.

Field
gene therapy
What they did
BioCardia is developing a therapy using the patient's own cells to treat heart failure, delivering them via minimally invasive catheter procedures.
Why it matters
This could help people with ischemic heart failure who lack other effective treatment options.
#cell therapy#heart failure#biocardia#cardiamp#regenerative medicine

Read the original →